Showing results (11-20 of 70) with videos related to
Sort By:
Pageof 7
Zhonghua Yi Xue Za Zhi|July 22, 2010
[Clinical study of multiple myeloma: a report of 182 cases]Lan Xu, Yan Wang, Wen Wu, et al.Zhongguo Shi Yan Xue Ye Xue Za Zhi|July 7, 2011
[A new artemisinin derivative SM1044 induces apoptosis of Kasumi-1 cells and its mechanism]Jing-Jing Liu, Ai-Mei Fei, Rui-Min Nie, et al.Clinical Immunology (Orlando, Fla.)|August 3, 2025
Interleukin-5 is an adjunctive biomarker for engraftment syndrome in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantationXing-Li Zhang, Meng-Meng Pan, Yaroslav Kaminskiy, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2026
A novel nanobody-based TCR-like CAR-T therapy targeting PRAME for the treatment of acute myeloid leukemiaXintong Liu, Jianfeng Li, Xue Li, et al.Journal of Translational Medicine|May 14, 2025
Mitochondrial dysfunction fuels drug resistance in adult T-cell acute lymphoblastic leukemiaShanshan Guo, Ekaterina Bourova-Flin, Sophie Rousseaux, et al.Frontiers of Medicine|August 31, 2021
Preclinical characterization and comparison between CD3/CD19 bispecific and novel CD3/CD19/CD20 trispecific antibodies against B-cell acute lymphoblastic leukemia: targeted immunotherapy for acute lymphoblastic leukemiaSisi Wang, Lijun Peng, Wenqian Xu, et al.Cancer Medicine|December 27, 2017
Induction of autophagy and autophagy-dependent apoptosis in diffuse large B-cell lymphoma by a new antimalarial artemisinin derivative, SM1044Chunyan Cheng, Tao Wang, Zhiqun Song, et al.Scientific Reports|February 24, 2025
Ixazomib or Lenalidomide combined with cyclophosphamide and dexamethasone in the treatment of elderly transplant-ineligible newly diagnosed multiple myelomaYan Wang, Yuan-Fang Liu, Shi-Wei Jin, et al.Annals of Translational Medicine|July 18, 2022
A case report of the metagenomics next-generation sequencing for early detection of central nervous system mucormycosis with successful rescue in patient with recurrent chronic lymphocytic leukemiaJiaojiao Zhang, Jing Luo, Xiangqin Weng, et al.Frontiers of Medicine|October 20, 2021
Chidamide inhibits the NOTCH1-MYC signaling axis in T-cell acute lymphoblastic leukemiaMengping Xi, Shanshan Guo, Caicike Bayin, et al.Pageof 7